Cobalamin (Cbl, vitamin B12) is an essential micronutrient that is synthesized only by bacteria. Mammals have developed a complex system for internalization of this vitamin from the diet. Three binding proteins (haptocorrin, intrinsic factor, transcobalamin (TC)) and several specific cell surface receptors are involved in the process of intestinal absorption, plasma transport and cellular uptake. The recent literature on the binding proteins is briefly reviewed. A structural study is presented addressing a unique feature of TC among the three proteins, i.e., the displacement of the weak Co(III)-ligand H 2 O at the upper (or b) axial side of H 2 O-Cbl by a histidine side chain. We have investigated crystallographically the b-ligand exchange on Cbl bound to TC by crystallization of bovine holo-TC in the presence of either cyanide or sulfite. The resulting electron density maps show that the histidine side chain has been displaced by an exogenous ligand CN 7 or SO 2À 3 to a lower extent than expected based on their higher affinity for Co and excess concentration with respect to histidine. This may reflect either reduced affinities of CN 7 and SO 2À 3 or the advantageous binding of the protein-integrated His-residue when competing for the b-site of Cbl bound to TC. The loop hosting the histidine residue appears more flexible after disruption of the coordination bond His-Cbl but no other differences are observed in the overall structure of holo-TC. These structural results are discussed in relation to a possible physiological role of histidine substitution for H 2 O and regarding the role of b-conjugated Cbl-analogues recently proposed for targeted delivery of imaging agents. IUBMB Life, 59: 722-729, 2007 
INTRODUCTION
Cobalamin (Cbl, vitamin B 12 ) is an essential micronutrient for mammals and is synthesized only in bacteria. Intestinal microorganisms produce Cbl in the colon of humans and animals which is, however, not absorbed and thus vitamin B 12 must be supplied with the food. In mammals, the assimilation and transport of Cbl is performed by three successive proteins, haptocorrin (HC), gastric intrinsic factor (IF) and transcobalamin (TC) (1 -3), see Fig. 1 . Cbl is required by cells as the basis for two enzyme cofactors, methyl-Cbl for methionine synthase and 5 0 -deoxyadenosyl-Cbl (Ado-Cbl) for methylmalonyl-CoA mutase (4) . In the stomach, Cbl is initially bound to salivary HC. After proteolytic cleavage of HC into two or three fragments in the duodenum, Cbl is transferred to IF. Mucosal cells in the terminal ileum absorb the IF-Cbl complex via endocytosis by the cubilin-amnionless receptor complex (5) . In the enterocyte, Cbl is liberated from IF and appears in blood bound to TC which carries Cbl to cells (6) . Only the fraction of Cbl bound to TC is rapidly taken up via endocytosis by a specific receptor of yet unknown structure which is present on most cell types (7) . The other Cbltransporting protein in plasma is HC. Its ability to facilitate cellular uptake of Cbl is quite limited, but HC is thought to function as a storage protein and as scavenger of inactive Cblanalogues. The precise physiological role of HC within the complex process of Cbl internalization is not yet fully discovered. After cellular uptake of TC-Cbl, the protein moiety is degraded in lysozomes to release Cbl for further conversion into the important cofactors (8) .
A genetic analysis suggested that the three binding proteins have a common evolutionary origin and that TC has diverged first from the ancestral gene (9) . Analyses of structural properties and binding kinetics have been greatly facilitated by the successful production of recombinant IF (10, 11) and TC (12, 13) . Recently, the structures of human and bovine TC in complex with Cbl have been solved by X-ray crystallography which permitted a detailed description of the mode of Cbl-binding (14) . So far, no crystal structures of IF and HC have been reported but a homology modelling was recently presented on the basis of the TC structures and a multiple sequence alignment of IF and HC with the two TC forms (15) .
The transporters possess a two-domain architecture in which a larger N-terminal domain ('a-domain'), composed of 12 a-helices in an a 6 -a 6 barrel and a short 3/10 helix, is connected by a flexible linker region to a smaller C-terminal domain ('b-domain') consisting mainly of two b-sheets (Fig. 2) . The b-domain resembles a domain of the functionally unrelated membrane protein squalene-hopene cyclase while the b-domain has been found to belong to a superfamily which is defined by the presence of the b-grasp fold suggested to be involved in the binding of soluble ligands (16) .
The homologous Cbl-transporters show about 25% overall sequence identity but possess considerably higher similarity in the vicinity of the Cbl-binding site. The regions of elevated sequence similarity were mapped on the experimentally determined human TC structure. Regarding the a-domain, these regions coincide with the six inner (even-numbered) helices, i.e., the core of the domain. As for the b-unit, the conserved residues are spread over the entire domain. An experimental proof of a two-domain architecture in human IF has been given previously (17, 18) . Three conserved disulphide bridges are present in the N-terminal domain of all human Cbl-transporters. HC contains an additional S-S bridge in the C-terminal domain where Cys365 and Cys370 connect the b-strands b4 and b5.
IF and (to an even higher extent) HC are glycosylated, but not TC (2) . The IF model shows glycosylation sites exclusively on the a-domain, as was confirmed experimentally (17) . Instead, HC also possesses two potential glycosylation sites on the a-domain which fall on the surface region proposed as receptor-recognition site of TC (14, 19) . The presence of carbohydrates on the a-domain of HC, but not on TC, may therefore explain how cell surface receptors for TC discriminate between the two plasma Cbl-transporters TC and HC. The lack of carbohydrates of IF does not effect receptorbinding of IF (20) and suggests that the protein surface involved in receptor-recognition is on the a-domain. However, the presence of both domains was recently found to be required for binding of IF to its specific receptor cubilin (18) .
The B 12 transport proteins have extraordinary affinity for the vitamin (K d values 5 1 pM) (10) . The Cbl ligand, with its 5,6-dimethylbenzimidazole (DMB) moiety coordinated to the Co ion ('base-on' form), is tightly enclosed in the domain interface. Most of the polar and hydrophobic interactions between Cbl and the proteins are conserved, in particular the van der Waals contacts of the buried DMB moiety and the H-bond interactions of the corrin side chains; a finding that is consistent with their similar equilibrium dissociation constants. The solvent accessible surface of Cbl increases from HC (%39 Å 2 or 3.2%) via TC (%80 Å 2 or 6.6%) to IF (%163 Å 2 or 13.3%) (15) . In IF and TC, the corrin side chains d, e and f as well as an oxygen of the phosphate group possess restricted accessibility while side chain a -c are inaccessible (see Fig. 1 for naming convention). The same holds for HC where, in addition, side chain f is inaccessible. The 5 0 -hydroxyl group of the nucleotide moiety appears easily accessible to solvent water molecules.
The lower side of Cbl (termed a-side, Fig. 1 ) is occupied by the nucleotide moiety and is embedded in the protein. Most of the protein binding characteristics are determined by structural features on this side of Cbl, rather than on the upper axial side (discussed further below). One example concerns the differences among the transporters regarding their specificity for Cbl analogues, which are as well produced by bacteria (21) . An early study (21) demonstrated that the affinity of both IF and TC for different Cbl analogues decreases upon modification of the corrin side chains or the nucleotide moiety. In contrast, HC tolerates major structural differences and even the total lack of the nucleotide moiety. Recent studies were focused on the influence of modifications at the nucleotide moiety on ligand recognition (22, 23) . These assays allowed to file Cbl-binding specificities in the order HC ( TC 5 IF. The likely physiological role thereof implies that the most specific protein IF selects in the first place genuine Cbl among Cbl analogues in the diet, whereas HC in the blood plasma acts as a scavenger of potentially toxic Cblanalogues that can harmfully compete for the binding site of Cbl in methionine synthase and methyl-malonyl-CoA mutase, thus exploiting its lowest level of discrimination among the three transporters (23) . Ligand specificity has also been investigated from a structural point of view (15) . Many interactions between Cbl and its binding site in the interface of the two domains are found to be conserved among the transporters. A structural comparison suggests that the determinant of specificity regarding Cbl ligands with modified nucleotide moiety resides in the b-hairpin motif b3 -turn -b4 of the smaller C-terminal domain. In haptocorrin, it provides hydrophobic contacts to the DMB moiety through the apolar part of Arg357, Trp359 and Tyr362. Together, these large side chains may compensate for the missing nucleotide upon cobinamide binding. Intrinsic factor possesses only the Trp and transcobalamin only the Tyr, consistent with their low affinity for cobinamide.
Besides ligand specificity, the a-side of Cbl appears to determine also the order in which the two domains bind the ligand. A depression in the otherwise flat interface of the a-domain to the b-domain accommodates about half of the ligand and a small portion of the b-domain corresponding to the turn between strands b3 and b4. In the holo-form of the transporters, this turn is wrapped around the nucleotide moiety of Cbl and appears in part trapped between the a-domain and Cbl. The involved residue is Trp348 in IF, Trp359 in HC (see Fig. 2 ) and Ser359 in TC. This smaller amino acid side chain in TC may account for the differences observed for the binding kinetics during the initial attachment of Cbl to the three proteins (23) . Regarding IF and HC, it can be concluded that this spatial arrangement can hardly be achieved if Cbl was already bound to the a-domain. Consequently, these two proteins bind Cbl first to b-domain whereupon the a-domain interacts with the Cblb-domain complex and induces the wrapping of the mentioned turn in the b-domain around Cbl's nucleotide moiety. An additional indication for the sequence of Cbl-binding 'b-domain before a-domain' is the observation for IF that Cbl binds to the isolated b-domain with higher affinity than to the isolated a-domain (18, 23) . Regarding TC, the binding kinetics is better interpreted by participation of both domains already in the early encounter with Cbl. None of the three proteins utilizes electrostatic attraction, as it can be expected for binding of a neutral ligand (15) .
The upper axial side (b-side) possesses solvent accessibility which is, however, restricted by the C-terminal part of the loop between helices a7 and a8. The b-side's accessibility to solvent is in agreement with experimental data on kinetics for binding of different Cbls. In fact, very similar binding constants are obtained for Cbl with both small b-coordinated ligands, such as CN or H 2 O, and larger ligands, such as 5 0 -deoxyadenosyl. This observation has long been considered as evidence that the b-side is at least partly solvent-exposed and thus does not play a role in determining ligand specificity (24) . The transporters show comparable affinities for the various Cbl forms and hardly discriminate between Cbls with different upper axial ligands (1) . A special feature may be attributed in this respect to TC, which treats H 2 O-Cbl differently to CN-Cbl and N 3 -Cbl by replacing the H 2 O ligand with a histidine side chain. Spectroscopic studies on the kinetics of ligand exchange at the upper axial position of H 2 O-Cbl upon binding to any of the three transporters revealed reactivity of Co with externally supplied histidine for IF-and HC-bound Cbl, but not for TC-bound Cbl (10) . In fact, the recent X-ray structure demonstrated that upon binding of H 2 O-Cbl to TC, the side chain of a histidine residue forms a coordination bond to the Co ion (14) . The observed bond length is about 0.2 Å longer than in the highresolution structure of free His-Cbl (25) , probably due to the onset of reduction of the Co(III) ion induced by X-rays during crystallographic data collection. The physiological function of histidine substitution for H 2 O is unknown. The Co-coordinating histidine in human and bovine TC is conserved among TCs from other sources but it is not in IF or HC (14) where H 2 O remains coordinated.
The interest in the upper (b)-axial ligand substitutions on Cbl arises not only from a putative biological role but also from the application of Cbl-based bioconjugates as vehicles for the targeted delivery of therapeutic or diagnostic molecules. Such bioconjugates show potential as cytotoxic drugs or imaging agents in cancer treatment (26) or as Cblcompetitors to selectively block cell growth in the treatment of AIDS-related lymphoma (27) or cancer (28) . These applications are based on the observation that proliferating cells express more surface receptors for holo-TC, and thus take up proportionally more Cbl, than cells in the stationary phase (26, 29) . Binding of Cbl bioconjugates has been studied extensively for TC (27, 30 -32) . Attachment of a molecule to Cbl had different effects on the interaction with TC depending on the type and location of the attached conjugate. This was systematically investigated in competitive binding assays using [ 57 Co]-CN-Cbl. Biotin conjugates attached either to the Co ion or the 5 0 -hydroxyl of the ribose moiety had little effect on binding (27) . Increasingly strong impairment of binding was observed for conjugation at the corrin side chains in the row e, b, d and c. These results were rationalized by the three-dimensional structure of human holo-TC (14) . It was shown that sites with low steric hindrances are best suited for conjugation because of a minor impact on the binding. Among the most promising sites we can mention the b-axial position of Co, the 5 0 -hydroxyl of ribose and the side chain e. It should be noted, however, that even though affinity for bioconjugates may be decreased by a factor of 100 -1000 in comparison to genuine Cbl, the transporters would still firmly bind the bioconjugates under physiological conditions (23) .
Herein we investigate the b-axial ligand substitution on Cbl bound to bovine TC by X-ray crystallography. The holo-form of the protein was crystallized in the presence of potassium cyanide or ammonium sulfite with the aim to prove the feasibility of this approach to prepare complexes of TC-Cbl-CN and TC-Cbl-SO 3 and to study conformational differences between the protein with and without histidine coordination. We discuss the implications of our structural results for the binding of bioconjugates with modifications on the b-side of the Co ion and for the putative physiological function of b-axial histidine substitution for H 2 O.
EXPERIMENTAL PROCEDURES

Crystallization
Recombinant bovine TC was expressed in Pichia pastoris and prepared as described previously (12) . Bovine TC was crystallized in the presence of either KCN or (NH 4 ) 2 SO 3 by the hanging drop vapour diffusion technique in two different crystal forms. Both a monoclinic and a trigonal form grew from 28% PEG 8000, 0.2 M magnesium acetate, 0.1 M TRIS pH 8.5, 20% 2-methyl-2,4-pentadiol and either 15 mM KCN or 40 mM (NH 4 ) 2 SO 3 . 1 ml of protein at 0.5 mM (25 mg ml 71 ) in 1 M NaCl, 0.1 M TRIS, pH 7.5 was mixed with 1 ml of reservoir. Crystals grew in 2 -4 days at a temperature of 208C.
X-ray Data Collection, Processing and Structure Refinement
Diffraction data were collected at the XRD beamline of the ELETTRA synchrotron radiation source (Trieste, Italy) at 1.2 Å wavelength and cryogenic temperature (100 K). Data were processed with MOSFLM/SCALA (33) . The Protein Data Bank entries 2BB6 and 2BBC were used as starting models for refinement of structures of the monoclinic and trigonal crystal form, respectively. The sets of R-free flagged reflections already used for the starting models were transferred to the CN-Cbl and SO 3 -Cbl data sets. Rigid body refinement was followed by restrained refinement together with TLS refinement in REFMAC5 (34) . For the monoclinic crystal form (4 molecules in the asymmetric unit), also noncrystallographic symmetry restraints were applied. Model rebuilding was carried out with COOT v0.3.1 (35) . Geometric restraints for CN-Cbl were taken from the Cambridge Structural Database entry WIKXUJ (36) and for SO 3 -Cbl from entry NOJKIG (37) . Table 1 compiles processing and refinement statistics. Atomic coordinates and structure factors have been deposited in the Protein Data Bank (http://www.rcsb.org) with accession number 2V3N for TCCbl-CN and 2V3P for TC-Cbl-SO 3 . (39) . These two strong ligands are therefore expected to be capable of displacing the imidazole side chain of the protein residue His175 which was found to coordinate to the Co ion in the X-ray structure of bovine TC (14) . The kinetics of the b-ligand exchange in human holo-TC has been studied in detail for the ligands CN 7 and N À 3 (10, 13).
RESULTS AND DISCUSSION
Cyanide (CN
Crystals of bovine TC were grown in the presence of either KCN or (NH 4 ) 2 SO 3 , employing otherwise the same conditions as for the crystallization of bovine holo-TC alone. The fact that the resulting crystals are isomorphous to those grown in the absence of the substituting ligands indicate that conformational changes in TC induced by these ligands (if any) did not influence the crystal packing. The molar excess of KCN over TC was 30-fold and 80-fold relative to the weaker ligand SO 2À 3 . Compared to crystals of TC-His-Cbl, the diffraction quality of the trigonal crystal form of TC-Cbl-CN and TCCbl-SO 3 was slightly lower and electron density maps for these two structures were obtained at a resolution of 2.7 and 2.9 Å , respectively (see Table 1 for data and model statistics).
Electron density maps (with coefficients 2F obs -F calc and F obs -F calc ) clearly reveal that the original histidine side chain on the b-side of Cbl has been displaced. Difference maps calculated without an upper axial ligand in the refined model show significant peaks at the position of the former imidazole ring of His175 (Fig. 3) . In the map for TC-Cbl-CN, a 3.6s difference peak is present at a distance of 2.0 Å from the Co ion. In the corresponding map for TC-Cbl-SO 3 , a 6.1s peak is observed at a distance of 2.0 Å . The respective ligand was then inserted in the model, applying geometric restraints of high resolution structures of CN-Cbl and SO 3 -Cbl and assuming full occupancy. However, from inspection of the resulting difference maps it was evident that the true occupancy is below one, especially for the SO 2À
3 . An accurate determination of the occupancy is hampered by the low resolution of the available data and due to the correlation of this parameter with the atomic displacement parameter (here, the individual B-factor). The latter has been refined isotropically while the occupancy was adjusted in steps of 0.1 to best account for the residual difference density. The best approximation for the cyanide occupancy is 0.8 and for the sulfite ligand 0.5.
It is remarkable that the histidine side chain has not been completely displaced after incubation with an excess of the high-affinity ligands CN 7 and SO 2À 3 for several days. This observation may be explained by high 'local concentration' of the histidine residue present in the vicinity of the Co ion as integrated part of the protein environment. Another feasible explanation implies hampered access of external ligands to the b-face of Cbl and/or lower stability of the b-contact in CN-Cbl and SO 3 -Cbl complexes when they are bound to TC.
The loop with His175 spans from His167 to His175 and is disordered from Lys168 to Asp174 in the crystal structure of TC-His-Cbl (14) . Partially missing electron density in this region was interpreted as elevated flexibility of this loop which participates neither in the intramolecular interactions nor in the crystal packing contacts, of the monoclinic and the trigonal crystal forms (PDB entry 2BB6 and 2BBC, respectively). In the two crystal structures described here, the coordination bond, anchoring the imidazole nitrogen Ne of His175 to the Co ion, is absent. Additionally, a higher disorder is observed for the detached loop, where the electron density of His175 and Ser176 is too weak to allow reliable building of the amino acid backbone.
We conclude from the comparison of the structures with and without histidine coordination, that conformational differences are spatially limited to the histidine-hosting loop. Protein stability, of either the b-domain alone or the sandwich complex a-domain -Cbl-b-domain, is evidently not influenced by the lack of the coordination bond. However, since the b-ligand was exchanged when Cbl was already bound to TC, it cannot be excluded that the binding process might be altered at the first steps of encounter between Cbl and the protein.
It is tempting to attribute a physiological function to the substitution of the imidazole for H 2 O because the involved histidine residue is conserved among the seven mammalian variants of TC analyzed so far (14) . One should recall that IF and HC do not possess this feature and thus, a potential biological role of the substitution reaction should be specific to TC. Several hypotheses have been suggested in the literature so far. The first suggests that different conformations of Hison and His-off TC-Cbl complexes might result in different pathways of the vitamin's trafficking (13) . This idea implies the recognition of these conformations by the cell surface receptor. The structure of the receptor in complex with holo-TC is not known to date. Hence one is limited to the statement that the interactions between the receptor and holo-TC must be very sensitive to the small structural difference caused by the loss of histidine coordination. Moreover, the site of receptor-binding by holo-TC was recently proposed to be on another part of the a-domain based on the high level of amino acid conservation among TC from seven mammalian sources in that surface region (14) . All the mentioned facts make the trafficking effect of His-coordination not very probable.
Another hypothesis is based on a protective role during B 12 transport in plasma. It might be advantageous to avoid coordination of exogenous molecules to the Co ion to facilitate intracellular reductive conversion of Cbls to the active coenzymes methyl-Cbl and Ado-Cbl. The involved processes are, however, not fully elucidated so far. Some degree of protection in TC-His-Cbl against potential b-ligand substituents (CN 7 , N À 3 ) has been observed spectroscopically (10) . It should be noted that only weak b-ligands would be completely displaced by the imidazole, whereas stronger ligands, such as CN . Another aspect concerns the protein solubility, which in vitro depends on the type of b-ligand present on Cbl in complex with TC. Thus, the complex with H 2 O-Cbl remained soluble at concentrations which lead to irreversible precipitation of CN-Cbl and N 3 -Cbl (13) . Yet, the effect of precipitation seems to be of marginal importance at the low physiological concentration of TC-Cbl.
At this point the question arises about the type and concentration of molecules in the blood that can compete for the b-ligand position. Detailed studies under physiological conditions are required to reveal whether the histidine coordination in the TC-His-Cbl complex is of biological importance. Since TC is available in recombinant form, useful information might be collected using point mutations of the histidine residue.
The current study has been undertaken keeping in mind the medical potential of Cbl-based bioconjugates with the b-attached ligands. A recent example concerns a Cbl-cisplatin conjugate where the cyanide of CN-Cbl was used as a bridge to attach an active substance (40) . Both in vitro and in vivo tests of cellular uptake of this bioconjugate require complexation with the transport proteins. This may be accomplished by denaturing holo-TC and subsequent incubation of apo-TC with the bioconjugate. Our results suggest the feasibility of an alternative procedure if the custom method resulted in illfolded or unstable conformations. First, TC-His-Cbl is converted to TC-Cbl-CN by adding cyanide. After removal of excessive cyanide, cisplatin is conjugated at a temperature that does not impair the stability of the complex. We intend to investigate these procedures in a future work.
